The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Suppression of hepcidin during anemia requires erythropoietic activity
Open accessAbstract
Hepcidin, the principal iron regulatory hormone, regulates the absorption of iron from the diet and the mobilization of iron from stores. Previous studies indicated that hepcidin is suppressed during anemia, a response that would appropriately increase the absorption of iron and its release from stores. Indeed, in the mouse model, hepcidin-1 was suppressed after phlebotomy or erythropoietin administration but the suppression was reversed by inhibitors of erythropoiesis. The suppression of hepcidin necessary to match iron supply to erythropoietic demand thus requires increased erythropoiesis and is not directly mediated by anemia, tissue hypoxia, or erythropoietin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strikingly, anaemia and anoxia both suppress hepcidin production [245,339,340] (Fig 3), such that just while superoxide production is being enhanced by the anoxia there is more iron being absorbed from the intestine and effluxed into the circulation.”
In the citing paper
“To correct this, all animals were conditioned on a low-iron diet (2-4 ppm iron; Teklad diet TD.80396, Envigo) for 5-7 days prior to, and throughout the duration of, all experiments.”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [53]
In the citing paper
“Our data established that HIF activation in hepatocytes suppresses hepcidin indirectly through EPO-mediated stimulation of erythropoiesis”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Self-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Self-citationPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Self-citationA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214
Rund, D. G., & Rachmilewitz, E. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 936
Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801
Regulators of iron balance in humans [see comments]
Finch, C. (1994) · Blood · doi:10.1182/blood.v84.6.1697.1697 · Cited by 455
Research works printed but not linked: 3
- Mosby's Drug Consult. Stat!Ref Online Electronic Medical Library (15). http://www.mosbydrugs.com. Accessed June 10, 2005.
- 2005, Eur J Clin Invest., 35, 13
- Cutnell JD, Johnson KW. Physics. 4th ed. New York, NY John Wiley; 1997.
Cited by
Sorted by citations
Items 101–200 of 472
Mitochondrial Mayhem: The Mitochondrion as a Modulator of Iron Metabolism and Its Role in Disease
Huang, M. L.-H., Lane, D. J. R., & Richardson, D. R. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3921 · Cited by 103
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
Coffey, R., & Ganz, T. (2018) · HemaSphere · doi:10.1097/hs9.0000000000000035 · Cited by 112
Self-citationde Francisco, Á. L. M., Stenvinkel, P., & Vaulont, S. (2008) · NDT Plus · doi:10.1093/ndtplus/sfn176 · Cited by 101
Chapin, J. C., & Giardina, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00040-8 · Cited by 101
Troutt, J. S., Rudling, M., Persson, L., Ståhle, L., Angelin, B., Butterfield, A. M., Schade, A. E., Cao, G., & Konrad, R. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.186866 · Cited by 100
Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H. Y., et al. (2016) · Blood · doi:10.1182/blood-2015-11-681494 · Cited by 97
The mutual control of iron and erythropoiesis
Camaschella, C., Pagani, A., Nai, A., & Silvestri, L. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12505 · Cited by 102
Iron metabolism: current facts and future decisions
Tandara, L., & Salamunić, I. (2012) · Biochemia Medica · doi:10.11613/bm.2012.034 · Cited by 102
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Coyne, D. W. (2011) · Kidney International · doi:10.1038/ki.2011.141 · Cited by 97
Hereditary hemochromatosis in the post- HFE era
Olynyk, J. K., Trinder, D., Ramm, G. A., Britton, R. S., & Bacon, B. R. (2008) · Hepatology · doi:10.1002/hep.22507 · Cited by 97
Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors
Pasricha, S., McQuilten, Z., Westerman, M., Keller, A. J., Nemeth, E., Ganz, T., & Wood, E. M. (2011) · Haematologica · doi:10.3324/haematol.2010.037960 · Cited by 99
Self-citationvan Dijk, B. A. C., Laarakkers, C. M., Klaver, S. M., Jacobs, E. M. G., van Tits, L. J. H., Janssen, M. C. H., & Swinkels, D. W. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07273.x · Cited by 92
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 95
Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 98
Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia
Michels, K. R., Zhang, Z., Bettina, A. M., Cagnina, R. E., Stefanova, D., Burdick, M. D., Vaulont, S., Nemeth, E., Ganz, T., & Mehrad, B. (2017) · JCI Insight · doi:10.1172/jci.insight.92002 · Cited by 93
Self-citationVolke, M., Gale, D. P., Maegdefrau, U., Schley, G., Klanke, B., Bosserhoff, A.-K., Maxwell, P. H., Eckardt, K.-U., & Warnecke, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007875 · Cited by 93
Iron Loading and Overloading due to Ineffective Erythropoiesis
Tanno, T., & Miller, J. L. (2010) · Advances in Hematology · doi:10.1155/2010/358283 · Cited by 94
The function of heme-regulated eIF2α kinase in murine iron homeostasis and macrophage maturation
Liu, S., Suragani, R. N. V. S., Wang, F., Han, A., Zhao, W., Andrews, N. C., & Chen, J.-J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32084 · Cited by 91
de Mast, Q., Nadjm, B., Reyburn, H., Kemna, E. H. J. M., Amos, B., Laarakkers, C. M. M., Silalye, S., Verhoef, H., Sauerwein, R. W., Swinkels, D. W., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/595790 · Cited by 89
Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
Nemeth, E. (2009) · Advances in Hematology · doi:10.1155/2010/750643 · Cited by 88
Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice
Wang, C., Core, A. B., Canali, S., Zumbrennen‐Bullough, K. B., Özer, S., Umans, L., Zwijsen, A., & Babitt, J. L. (2017) · Blood · doi:10.1182/blood-2016-12-759423 · Cited by 92
Robach, P., Recalcati, S., Girelli, D., Gelfi, C., Aachmann‐Andersen, N. J., Thomsen, J. J., Norgaard, A. M., Alberghini, A., Campostrini, N., Castagna, A., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178095 · Cited by 89
A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
Bondu, S., Alary, A.-S., Lefèvre, C., Houy, A., Jung, G., Lefebvre, T., Rombaut, D., Boussaid, I., Bousta, A., Guillonneau, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5467 · Cited by 85
Self-citationTreating inflammation with the Janus Kinase inhibitor CP-690,550
Vijayakrishnan, L., Venkataramanan, R., & Gulati, P. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.10.004 · Cited by 87
Nemeth, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05585.x · Cited by 91
Lasocki, S., Millot, S., Andrieu, V., Lettéron, P., Pilard, N., Muzeau, F., Thibaudeau, O., Montravers, P., & Beaumont, C. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818103b9 · Cited by 84
Role of growth differentiation factor 11 in development, physiology and disease
Zhang, Y., Wei, Y. S., Liu, D., Liu, F., Li, X. A., Pan, L., Pang, Y., & Chen, D. (2017) · Oncotarget · doi:10.18632/oncotarget.20258 · Cited by 84
Current Status of Pharmacologic Therapies in Patient Blood Management
Goodnough, L. T., & Shander, A. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318273f4ae · Cited by 81
Agarwal, A. K., & Yee, J. (2019) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.04.005 · Cited by 83
Regulation of Hepcidin by Erythropoiesis: The Story So Far
Pasricha, S., McHugh, K., & Drakesmith, H. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050731 · Cited by 84
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
Swinkels, D. W., & Wetzels, J. F. M. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn267 · Cited by 79
Zumbrennen‐Bullough, K. B., & Babitt, J. L. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft443 · Cited by 82
Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice
Bartnikas, T. B., Andrews, N. C., & Fleming, M. D. (2011) · Blood · doi:10.1182/blood-2010-05-287359 · Cited by 77
Behavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors
Mast, A. E., Foster, T. M., Pinder, H. L., Beczkiewicz, C. A., Bellissimo, D. B., Murphy, A., Kovacevic, S., Wroblewski, V. J., & Witcher, D. R. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01823.x · Cited by 74
Uehata, T., Tomosugi, N., Shoji, T., Sakaguchi, Y., Suzuki, A., Kaneko, T., Okada, N., Yamamoto, R., Nagasawa, Y., Kato, K., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr431 · Cited by 75
Hepcidin: A novel peptide hormone regulating iron metabolism
Singh, B. M., Arora, S., Agrawal, P., & Gupta, S. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.014 · Cited by 77
-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload
Melchiori, L., Gardenghi, S., & Rivella, S. (2010) · Advances in Hematology · doi:10.1155/2010/938640 · Cited by 77
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Reichert, C. O., da Cunha, J., Levy, D., Maselli, L. M. F., Bydlowski, S. P., & Spada, C. (2017) · Acta Haematologica · doi:10.1159/000471838 · Cited by 77
Iron metabolism in thalassemia and sickle cell disease
Mariani, R., Trombini, P., Matteo Pozzi, & Piperno, A. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.006 · Cited by 76
Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia
Cheng, P., Jiao, X., Wang, X., Lin, J.-H., & Cai, Y. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0102-9 · Cited by 74
2-Oxoglutarate-dependent oxygenases control hepcidin gene expression
Braliou, G. G., Falzacappa, M. V. V., Chachami, G., Casanovas, G., Muckenthaler, M. U., & Simos, G. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.021 · Cited by 68
High‐sensitive radioimmunoassay for human serum hepcidin
Grebenchtchikov, N. I., Geurts-Moespot, A. J., Kroot, J. J., den Heijer, M., Tjalsma, H., Swinkels, D. W., & Sweep, F. C. G. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07758.x · Cited by 65
Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation
Kanda, J., Mizumoto, C., Kawabata, H., Tsuchida, H., Tomosugi, N., Matsuo, K., & Uchiyama, T. (2008) · Haematologica · doi:10.3324/haematol.12399 · Cited by 64
Kong, W.-N., Gao, G., & Chang, Y.-Z. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-19 · Cited by 71
What can we learn from ineffective erythropoiesis in thalassemia?
Oikonomidou, P. R., & Rivella, S. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.10.001 · Cited by 67
Optimal serum ferritin level range: iron status measure and inflammatory biomarker
DePalma, R. G., Hayes, V. W., & O’Leary, T. J. (2021) · Metallomics · doi:10.1093/mtomcs/mfab030 · Cited by 65
Development of a novel immunoassay for the iron regulatory peptide hepcidin
Busbridge, M., Griffiths, C., Ashby, D. R., Gale, D. P., Jayantha, A., Sanwaiya, A., & Chapman, R. (2009) · British Journal of Biomedical Science · doi:10.1080/09674845.2009.11730263 · Cited by 63
Transferrin-a modulates hepcidin expression in zebrafish embryos
Fraenkel, P. G., Gibert, Y., Holzheimer, J., Lattanzi, V. J., Burnett, S. F., Dooley, K. A., Wingert, R. A., & Zon, L. I. (2008) · Blood · doi:10.1182/blood-2008-06-165340 · Cited by 66
Suppressive Effects of Retinoids on Iron-Induced Oxidative Stress in the Liver
Tsuchiya, H., Akechi, Y., Ikeda, R., Nishio, R., Sakabe, T., Terabayashi, K., Matsumi, Y., Ashla, A. A., Hoshikawa, Y., Kurimasa, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.027 · Cited by 62
Vela, D. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0008-7 · Cited by 65
The erythroblastic island as an emerging paradigm in the anemia of inflammation
Hom, J., Dulmovits, B. M., Mohandas, N., & Blanc, L. (2015) · Immunologic Research · doi:10.1007/s12026-015-8697-2 · Cited by 66
Kawabata, H. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2365-3 · Cited by 64
Low hemoglobin deferral in blood donors
Mast, A. E. (2013) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2013.11.001 · Cited by 61
Toblli, J. E., & Angerosa, M. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s55499 · Cited by 65
Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study
den Elzen, W. P. J., de Craen, A. J. M., Wiegerinck, E. T. G., Westendorp, R. G. J., Swinkels, D. W., & Gussekloo, J. (2012) · Haematologica · doi:10.3324/haematol.2012.068825 · Cited by 61
Darshan, D., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2010) · Haematologica · doi:10.3324/haematol.2010.022426 · Cited by 61
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
Donker, A. E., van der Staaij, H., & Swinkels, D. W. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100866 · Cited by 76
Iron deficiency in critically ill patients: highlighting the role of hepcidin
Heming, N., Montravers, P., & Lasocki, S. (2011) · Critical Care · doi:10.1186/cc9992 · Cited by 61
Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly
Gammella, E., Diaz, V., Recalcati, S., Buratti, P., Samaja, M., Dey, S., Noguchi, C. T., Gassmann, M., & Cairo, G. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00410.2014 · Cited by 59
Cell‐type‐specific insights into iron regulatory processes
Mleczko‐Sanecka, K., & Silvestri, L. (2020) · American Journal of Hematology · doi:10.1002/ajh.26001 · Cited by 64
Nramp1 equips macrophages for efficient iron recycling
Soe-Lin, S., Sheftel, A. D., Wasyluk, B., & Ponka, P. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.02.013 · Cited by 56
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis
Bozzini, C., Campostrini, N., Trombini, P., Nemeth, E., Castagna, A., Tenuti, I., Corrocher, R., Camaschella, C., Ganz, T., Olivieri, O., et al. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.10.001 · Cited by 57
Self-citationKaneko, Y., Miyajima, H., Piperno, A., Tomosugi, N., Hayashi, H., Morotomi, N., Tsuchida, K., Ikeda, T., Ishikawa, A., Ota, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0259-8 · Cited by 56
Iron Metabolism and Its Disorders
Harvey, J. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-370491-7.00009-x · Cited by 57
Ramos, P., Guy, E. C., Chen, N., Proenca, C. C., Gardenghi, S., Casu, C., Follenzi, A., van Rooijen, N., Grady, R. W., de Sousa, M. A. B., et al. (2010) · Blood · doi:10.1182/blood-2010-09-307462 · Cited by 55
Hepcidin: another culprit for complications in patients with chronic kidney disease?
Nakanishi, T., Hasuike, Y., Otaki, Y., Kida, A., Nonoguchi, H., & Kuragano, T. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr410 · Cited by 53
Iron dysregulation in beta-thalassemia
Leecharoenkiat, K., Lithanatudom, P., Sornjai, W., & Smith, D. R. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.07.035 · Cited by 52
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression
Gordeuk, V. R., Miasnikova, G. Y., Sergueeva, A. I., Niu, X., Nouraie, M., Okhotin, D. J., Polyakova, L. A., Ammosova, T., Nekhai, S., Ganz, T., et al. (2011) · Blood · doi:10.1182/blood-2011-03-345512 · Cited by 51
Self-citationOncostatin M is a potent inducer of hepcidin, the iron regulatory hormone
Chung, B., Verdier, F., Matak, P., Deschemin, J., Mayeux, P., & Vaulont, S. (2010) · The FASEB Journal · doi:10.1096/fj.09-152561 · Cited by 51
Sasaki, Y., Noguchi‐Sasaki, M., Yasuno, H., Yorozu, K., & Shimonaka, Y. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1217-4 · Cited by 50
Yun, S., & Vincelette, N. D. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.02.006 · Cited by 52
Function of the hemochromatosis protein HFE: Lessons from animal models
Pantopoulos, K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6893 · Cited by 49
Crosstalk between Iron Metabolism and Erythropoiesis
Li, H., & Ginzburg, Y. Z. (2010) · Advances in Hematology · doi:10.1155/2010/605435 · Cited by 53
Harvey, J. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0173-9.00004-x · Cited by 49
Aydemir, F., Jenkitkasemwong, S., Gulec, S., & Knutson, M. D. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.094052 · Cited by 49
Brown, D. E., Libby, S. J., Moreland, S. M., McCoy, M. W., Brabb, T., Stepanek, A., Fang, F. C., & Detweiler, C. S. (2013) · Veterinary Pathology · doi:10.1177/0300985813478213 · Cited by 48
Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF
Wheeler, J. A., & Clinkenbeard, E. L. (2019) · Current Molecular Biology Reports · doi:10.1007/s40610-019-0110-9 · Cited by 48
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines
Zhang, X., & Rovin, B. H. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.08.005 · Cited by 49
Animal Models of Anemia of Inflammation
Rivera, S., & Ganz, T. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2009.06.003 · Cited by 49
Self-citationSex Differences in Iron Status and Hepcidin Expression in Rats
Kong, W.-N., Niu, Q.-M., Ge, L., Zhang, N., Yan, S., Chen, W., Chang, Y., & Zhao, S.-E. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0051-3 · Cited by 50
Janssen, M. C. H., & Swinkels, D. W. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.02.004 · Cited by 46
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
Querbes, W., Bogorad, R. L., Moslehi, J., Wong, J., Chan, A. Y., Bulgakova, E., Kuchimanchi, S., Akinc, A., Fitzgerald, K., Koteliansky, V., et al. (2012) · Blood · doi:10.1182/blood-2012-04-423715 · Cited by 45
Lanser, L., Burkert, F. R., Bellmann‐Weiler, R., Schroll, A., Wildner, S. M., Fritsche, G., & Weiß, G. (2021) · Metabolites · doi:10.3390/metabo11100653 · Cited by 46
Managing the Dual Nature of Iron to Preserve Health
Silvestri, L., Pettinato, M., Furiosi, V., Volpe, L. B., Nai, A., & Pagani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043995 · Cited by 49
TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis
Ganz, T., Nemeth, E., Rivella, S., Goldberg, P., Dibble, A., McCaleb, M. L., Guo, S., Monia, B. P., & Barrett, T. D. (2023) · Advances in Therapy · doi:10.1007/s12325-022-02421-w · Cited by 44
Self-citationFrazer, D. M., Wilkins, S. J., Darshan, D., Badrick, A. C., McLaren, G. D., & Anderson, G. J. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09104.x · Cited by 43
Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure
Srai, S. K., Chung, B., Marks, J., Pourvali, K., Solanky, N., Rapisarda, C., Chaston, T. B., Hanif, R., Unwin, R. J., Debnam, E. S., et al. (2010) · Kidney International · doi:10.1038/ki.2010.217 · Cited by 44
Paesano, R., Natalizi, T., Berlutti, F., & Valenti, P. (2012) · Pathogens and Global Health · doi:10.1179/2047773212y.0000000043 · Cited by 44
Increased Serum Iron Levels and Infectious Complications after Liver Transplantation
Chow, J. K. L., Werner, B. G., Ruthazer, R., & Snydman, D. R. (2010) · Clinical Infectious Diseases · doi:10.1086/654802 · Cited by 43
Hepcidin Concentrations in Serum and Urine Correlate with Iron Homeostasis in Preterm Infants
Müller, K., Springer, L., Poets, C. F., Westerman, M. E., & Franz, A. R. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.12.030 · Cited by 41
Effect of hepcidin antagonists on anemia during inflammatory disorders
Sagar, P., Angmo, S., Sandhir, R., Rishi, V., Yadav, H., & Singhal, N. K. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107877 · Cited by 44
Inhibitory effect of polysaccharides isolated from Angelica sinensis on hepcidin expression
Wang, K., Zeng, F., Liu, J., Guo, D. H., & Zhang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.02.015 · Cited by 42
Troutt, J. S., Butterfield, A. M., & Konrad, R. J. (2013) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21634 · Cited by 43
Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells
Silva-Carvalho, A. É., Cardoso, M. H. E. S., Alencar‐Silva, T., Bogéa, G. M. R., Carvalho, J. L., Franco, O. L., & Saldanha‐Araújo, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108021 · Cited by 41
Unexplained Aspects of Anemia of Inflammation
Price, E. A., & Schrier, S. L. (2010) · Advances in Hematology · doi:10.1155/2010/508739 · Cited by 43
Kartikasari, A. E. R., Wagener, F. A. D. T. G., Yachie, A., Wiegerinck, E. T. G., Kemna, E., & Winkels, D. W. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00494.x · Cited by 41
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
Tsuchiya, K., & Nitta, K. (2012) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12001 · Cited by 42
Advancements in anemias related to chronic conditions
Guidi, G. C., & Santonastaso, C. L. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.264 · Cited by 39
Regulation of cellular iron metabolism and its implications in lung cancer progression
Xiong, W., Wang, L., & Yu, F. (2014) · Medical Oncology · doi:10.1007/s12032-014-0028-2 · Cited by 39
Metadata
- Authors
- Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S.
- Affiliations
- University of California, Los Angeles (US)
- ORCID
- Ganz, Tomas
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-12-01
- Volume
- 108
- Issue
- 12
- Pages
- 3730-3735
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC1895477
- OpenAlex
- W1973313690
- Cited by
- 472
- References
- 40
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 16 · 2022: 10 · 2021: 22 · 2020: 18 · 2019: 16 · 2018: 21 · 2017: 38 · 2016: 15 · 2015: 27 · 2014: 37 · 2013: 37 · 2012: 35
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (K08 DK)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065029, K08 DK 07284-01)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hepcidin, anemia, erythropoiesis, erythropoietin, iron regulation, iron absorption, iron mobilization, phlebotomy, hypoxia
- MeSH terms
- Anemia, Animals, Hypoxia, Erythropoiesis, Erythropoietin, Female, Iron, Male, Iron, Dietary, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review